The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
The collaboration offers opportunities for training, research fellowships, workshops and conferences at palliative care centers managed by Ajit Isaac Foundation
US FDA and EMA accepted filings based on the data from OCARINA II, with EU approval anticipated mid-2024 and U.S. approval anticipated September 2024
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
US FDA approval based on NEURO-TTRansform Phase III results
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Subscribe To Our Newsletter & Stay Updated
